Gamida Cell is a cell and immune therapy visionary. The company’s world-class scientists have developed a broad platform technology to expand functional cells in culture to create unprecedented, life-saving cures for blood cancers such as leukemia and lymphoma and rare genetic diseases such as sickle cell disease.
Gamida Cell’s is well positioned to fill the unmet needs of several potentially multi-billion dollar markets by bringing allogeneic cell products to the clinic.
Gamida Cell has a broad worldwide patent portfolio and worldwide rights to all products.
The company has developed a cost effective and robust manufacturing process under GMP for each product and has in-house manufacturing capabilities.